This inventor holds 1 USPTO granted patent. Top assignee: Wockhardt Limited. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: M Madhav Reddy: Innovator in Antimicrobial Research
Introduction
M Madhav Reddy is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of antimicrobial research, particularly through his innovative patent. His work focuses on developing new generation antimicrobial compounds that have the potential to address critical health challenges.
Latest Patents
M Madhav Reddy holds a patent for "Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments." This invention relates to the creation of new antimicrobial agents that are effective against a wide range of pathogens. The patent encompasses not only the compounds themselves but also their optical isomers, diastereomers, enantiomers, and various forms such as pharmaceutically acceptable salts and hydrates.
Career Highlights
M Madhav Reddy is associated with Wockhardt Limited, a prominent pharmaceutical company. His work at Wockhardt has allowed him to contribute to the development of innovative medical solutions. He has been instrumental in advancing research that aims to improve health outcomes through effective antimicrobial therapies.
Collaborations
M Madhav Reddy has collaborated with notable colleagues in his field, including Noel John De Souza and Mahesh Vithalbhai Patel. These collaborations have fostered a productive environment for research and innovation, leading to significant advancements in antimicrobial science.
Conclusion
M Madhav Reddy's contributions to antimicrobial research exemplify the impact of innovation in healthcare. His patent reflects a commitment to developing effective medical solutions that can benefit society. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
